Early Monday morning Boston Children’s Computational Health Informatics Program (CHIP) flipped the switch to release C Tracker, the group’s first ever app to run on Apple’s ResearchKit system for clinical research. The app lets people living with hepatitis C track their health, medication use and quality of life over the course of months or years.
But it’s about more than health tracking; it’s about lowering barriers and making it easier for patients to participate in population-scale outcomes research on hepatitis C medications and how they respond to those medications in the real world. As CHIP director and C Tracker lead Ken Mandl, MD, MPH, said in a statement:
“Traditional clinical trials are plagued by abysmal accrual rates, slowing progress in discovering cures. We foresee a future where ResearchKit apps like C Tracker lower the barrier to participation and speed medical progress.
By and large, the data we have now about hepatitis C treatments come from traditional clinical trials. With C Tracker, we can listen to the patient voice to learn how people live with hepatitis in the real world.”